These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

59 related items for PubMed ID: 6875333

  • 1. [Studies on the appropriated interval of mass screening for cervical cancer].
    Kusanagi T, Kudo R, Ito E, Sagae S, Hori Y, Tamura H, Hayakawa O, Fujimura Y, Hashimoto M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jun; 35(6):782-6. PubMed ID: 6875333
    [Abstract] [Full Text] [Related]

  • 2. Appropriate frequency of mass-screening for uterine cervical cancer.
    Iwanari O.
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Oct; 39(10):1799-805. PubMed ID: 3429977
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Survey of screening for uterine cervical cancer in Wakayama city (author's transl)].
    Yokota H, Mabuchi Y, Hosomichi T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Dec; 33(12):2072-8. PubMed ID: 7338660
    [Abstract] [Full Text] [Related]

  • 8. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
    Schindeler S, Morrell S, Zuo Y, Baker D.
    J Med Screen; 2008 Dec; 15(1):36-43. PubMed ID: 18416954
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cervical cancer: cytological cervical screening in Iceland and implications of HPV vaccines.
    Sigurdsson K.
    Cytopathology; 2010 Aug; 21(4):213-22. PubMed ID: 20646020
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
    Ng EH, Ng FC, Tan PH, Low SC, Chiang G, Tan KP, Seow A, Emmanuel S, Tan CH, Ho GH, Ng LT, Wilde CC.
    Cancer; 1998 Apr 15; 82(8):1521-8. PubMed ID: 9554530
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Optimal frequency of cervical cancer cytology for mass-screening].
    Izutsu T, Kagabu T, Nishiya I.
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Mar 15; 35(3):297-304. PubMed ID: 6833815
    [Abstract] [Full Text] [Related]

  • 18. [Comparison of the clinical features of uterine cervical cancers detected by mass screening and voluntary visit].
    Yoh S, Hasuo Y, Tanaka H, Yakushizi M, Sakurai T.
    Gan To Kagaku Ryoho; 1988 Jun 15; 15(6):1949-57. PubMed ID: 3382243
    [Abstract] [Full Text] [Related]

  • 19. [The present status of mass population screening for cancer of the uterine cervix and the therapeutic results in the detected cases in Miyagi Prefecture].
    Sato S, Toki T, Yamauchi R, Wakisaka T, Sakahira H, Mori T, Yajima A, Suzuki M, Nasu I, Sato S, Kaneda N, Higashiiwai H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Feb 15; 35(2):127-33. PubMed ID: 6864010
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.